Why DocuSign Stock Shot Nearly 5% Higher Today

09:08pm, Monday, 17'th Oct 2022 The Motley Fool
There's noting like getting a reputation bolstered by a respected third party.

Why DocuSign Stock Shot Nearly 5% Higher Today

05:08pm, Monday, 17'th Oct 2022
There's noting like getting a reputation bolstered by a respected third party.
DocuSign's revenues grew ~5x from $519M in 2017 to an estimated $2.4B billion this year. So, why did we exit our DOCU stock position? Click here to find out.

DocuSign (DOCU) Gains As Market Dips: What You Should Know

10:00pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
In the latest trading session, DocuSign (DOCU) closed at $45.35, marking a +1.82% move from the previous day.
DocuSign Inc.’s (NASDAQ: DOCU) stock has limited downside as the negative catalysts have already played out, according to Wedbush. The Analyst: Daniel Ives upgraded the rating for DocuSign from Unde
James Cakmak, Clockwise Capital partner and portfolio manager, joins 'The Exchange' to discuss why he is betting on tech platforms over services.
Upgrades For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte

What 12 Analyst Ratings Have To Say About DocuSign

01:24pm, Wednesday, 12'th Oct 2022 Benzinga
DocuSign (NASDAQ:DOCU) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 5 5 0 Last 30D 0 0
Shares of Docusign Inc (NASDAQ:DOCU) are up 2.7% at $45.72 ahead of the bell, following an upgrade from Wedbush to "neutral" from "underperform.

3 IT Stocks to Sell Before They Die

12:27pm, Friday, 07'th Oct 2022
Cryptocurrencies are still facing a myriad of issues. For one, the value of most cryptos are still hovering around 52-week lows.

Solid Liquidity Aids DocuSign (DOCU), Escalating Expenses Ail

03:01pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Strong growth efforts and an increasing current ratio are beneficial for DocuSign (DOCU). However, escalating costs are a headwind.
Although shares of DocuSign Inc. (NASDAQ: DOCU) have lost around 64% year to date, there is further downside due to intensifying competition and execution issues, while Box Inc.’s (NYSE: BOX) value
Upgrades For Sensei Biotherapeutics Inc (NASDAQ:SNSE), Oppenheimer upgraded the previous rating of Perform to Outperform. For the second quarter, Sensei Biotherapeutics had an EPS of $0.34, compared t

Why DocuSign Stock Is Sliding Today

01:06pm, Monday, 03'rd Oct 2022 Benzinga
DocuSign Inc (NASDAQ: DOCU) shares are trading lower Monday following a downgrade from Morgan Stanley.  Morgan Stanley analyst Josh Baer downgraded DocuSign from Equal-Weight to Underweight and lo
Strong growth efforts and an increasing current ratio are beneficial for DocuSign (DOCU). However, escalating costs are a headwind.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE